Beranda8QQ • FRA
add
AbCellera Biologics Inc
Tutup sebelumnya
€2,25
Rentang hari
€2,21 - €2,21
Rentang tahun
€1,70 - €3,91
Kapitalisasi pasar
777,75 jt USD
Volume Rata-Rata
275,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 5,05 jt | -44,98% |
Biaya operasional | -271,00 rb | -101,02% |
Laba bersih | -34,21 jt | 27,44% |
Margin laba bersih | -677,43 | -31,88% |
Penghasilan per saham | -0,12 | 25,00% |
EBITDA | -26,04 jt | 55,50% |
Tarif pajak efektif | 26,95% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 625,61 jt | -17,75% |
Total aset | 1,36 M | -8,57% |
Total liabilitas | 304,47 jt | -9,32% |
Total ekuitas | 1,06 M | — |
Saham yang beredar | 297,99 jt | — |
Harga terhadap nilai buku | 0,63 | — |
Tingkat pengembalian aset | -7,40% | — |
Tingkat pengembalian modal | -8,97% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -34,21 jt | 27,44% |
Kas dari operasi | -8,00 jt | 59,21% |
Kas dari investasi | 35,70 jt | 246,79% |
Kas dari pembiayaan | 4,14 jt | 10,01% |
Perubahan kas bersih | 29,68 jt | 175,92% |
Arus kas bebas | -72,44 jt | -28.861,47% |
Tentang
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Didirikan
2012
Kantor pusat
Situs
Karyawan
596
